Effects of cilostazol on serum lipid concentrations and plasma fatty acid composition in type 2 diabetic patients with peripheral vascular disease

2003 ◽  
Vol 2 (4) ◽  
pp. 180-184 ◽  
Author(s):  
N. Nakamura ◽  
T. Hamazaki ◽  
H. Johkaji ◽  
S. Minami ◽  
K. Yamazaki ◽  
...  
Keyword(s):  
Fatty Acid Composition ◽  
Fatty Acid ◽  
Serum Lipid ◽  
Diabetic Patients ◽  
Plasma Fatty Acid ◽  
Peripheral Vascular ◽  
Type 2 Diabetic Patients ◽  
Plasma Fatty Acid Composition ◽  
Type 2 Diabetic

Fatty Acid Composition of Serum Lipid Fractions in Type 2 Diabetic Patients With Microalbuminuria

Diabetes Care ◽  
2003 ◽  
Vol 26 (3) ◽  
pp. 613-618 ◽  
Author(s):  
M. S. Perassolo ◽  
J. C. Almeida ◽  
R. L. Pra ◽  
V. D. Mello ◽  
A. L. Maia ◽  
...  
Keyword(s):  
Fatty Acid Composition ◽  
Fatty Acid ◽  
Acid Composition ◽  
Serum Lipid ◽  
Diabetic Patients ◽  
Type 2 Diabetic Patients ◽  
Lipid Fractions ◽  
Type 2 Diabetic

Effects of soybean D-LeciVita product on serum lipids and fatty acid composition in type 2 diabetic patients with hyperlipidemia

2006 ◽  
Vol 16 (6) ◽  
pp. 395-404 ◽  
Author(s):  
Danijela Ristić Medić ◽  
Vanja Ristić ◽  
Aleksandra Arsić ◽  
Marija Poštić ◽  
Gordana Ristić ◽  
...  
Keyword(s):  
Fatty Acid Composition ◽  
Fatty Acid ◽  
Acid Composition ◽  
Serum Lipids ◽  
Diabetic Patients ◽  
Type 2 Diabetic Patients ◽  
Type 2 Diabetic

Serum phospholipid fatty acid composition and insulin action in type 2 diabetic patients

Metabolism ◽  
2001 ◽  
Vol 50 (12) ◽  
pp. 1472-1478 ◽  
Author(s):  
Terezie Pelik[aacute]nov[aacute] ◽  
Ludmila Kazdov[aacute] ◽  
[Scaron][aacute]rka Chvojkov[aacute] ◽  
Ji[rcaron][iacute] Ba[scaron]e
Keyword(s):  
Fatty Acid Composition ◽  
Fatty Acid ◽  
Insulin Action ◽  
Phospholipid Fatty Acid ◽  
Diabetic Patients ◽  
Phospholipid Fatty Acid Composition ◽  
Serum Phospholipid ◽  
Type 2 Diabetic Patients ◽  
Type 2 Diabetic

Association of fatty acid profile in plasma lipid fractions with HbA1c in type 2 diabetic patients

2015 ◽  
Vol 36 (1) ◽  
pp. 23-33 ◽  
Author(s):  
Tomáš Čermák ◽  
Petr Laštovička ◽  
Vladimíra Mužáková ◽  
Martina Líbalová ◽  
Lucie Koukalová ◽  
...  
Keyword(s):  
Fatty Acid ◽  
Fatty Acid Profile ◽  
Plasma Lipid ◽  
Diabetic Patients ◽  
Type 2 Diabetic Patients ◽  
Lipid Fractions ◽  
Type 2 Diabetic

scholarly journals Plasma Fatty Acid-Binding Protein 4 Increases with Renal Dysfunction in Type 2 Diabetic Patients without Microalbuminuria

2008 ◽  
Vol 54 (1) ◽  
pp. 181-187 ◽  
Author(s):  
Anna Cabré ◽  
Iolanda Lázaro ◽  
Josefa Girona ◽  
Josep M Manzanares ◽  
Francesc Marimón ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Fatty Acid ◽  
Renal Dysfunction ◽  
Fatty Acid Binding Protein ◽  
Diabetic Patients ◽  
Type 2 Diabetic Patients ◽  
Fatty Acid Binding ◽  
Acid Binding Protein ◽  
Type 2 Diabetic

Abstract Background: Fatty acid–binding protein 4 (FABP4) has been linked to metabolic syndrome development, diabetes, and arteriosclerosis, but the role of FABP4 in target organ damage has not been assessed. We evaluated whether plasma FABP4 is associated with renal dysfunction in type 2 diabetic patients. Methods: In 263 individuals (161 type 2 diabetic patients and 102 healthy nondiabetic controls), we analyzed the correlation between FABP4 and creatinine or glomerular filtration index (MDRD-GFR) regarding the presence or absence of microalbuminuria. Patients with severe chronic kidney disease (MDRD-GFR <30 mL/min/1.73 m2) or albuminuria were not included. Results: FABP4 concentrations were higher in diabetic patients with MDRD-GFR <60 mL/min/1.73 m2 (P <0.001). We observed a significant, direct correlation between FABP4 and creatinine (r = 0.446, P <0.001) and an inverse correlation between FABP4 and MDRD-GFR (r = −0.511, P <0.001) in type 2 diabetic patients, but not in nondiabetic individuals. These correlations were sustained when only those patients without microalbuminuria were analyzed (r = 0.414, P <0.001 and r = −0.510, P <0.001, respectively). Type 2 diabetic patients with FABP4 in the highest tertile compared with those in the lower tertiles had increased adjusted odds ratios for moderate renal dysfunction [7.5 (95%CI 1.8–30.7), P = 0.005 and 15.3 (3.1–76.4), P = 0.001; respectively], independent of microalbuminuria. Conclusions: High FABP4 plasma concentrations are associated with high plasma creatinine and low MDRD-GFR in patients with type 2 diabetes even in the absence of microalbuminuria or clinically relevant alterations of creatinine and MDRD-GFR values. FABP4 concentrations should be taken into consideration as an early marker of kidney damage in patients with type 2 diabetes.

Sign in / Sign up

Export Citation Format

Share Document